Dysferlinopathy
What's New
Last Posted: Mar 15, 2023
- Genotype-phenotype correlation and natural history study of dysferlinopathy: a single-centre experience from India.
Nashi Saraswati, et al. Neurogenetics 2022 0 (1) 43-53 - A novel mutation in the DYSF gene in a patient with a presumed inflammatory myopathy.
Tang Jin, et al. Neuropathology : official journal of the Japanese Society of Neuropathology 2018 0 - Null variants in DYSF result in earlier symptom onset.
Park Hyung Jun, et al. Clinical genetics 2020 0 (3) 396-406 - The correlation of clinical evaluation with life quality and mental status in a Chinese cohort with dysferlinopathy.
Feng Xuelin, et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 0 259-264 - Molecular landscape of DYSF mutations in dysferlinopathy: From a Chinese multicenter analysis to a worldwide perspective.
Zhong Huahua, et al. Human mutation 2021 0 (12) 1615-1623 - [Analysis of genetic variants in five pedigrees affected with Dysferlinopathy].
Xia Yanjie, et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021 0 (3) 205-209 - Abnormal Expression of Dysferlin in Blood Monocytes Supports Primary Dysferlinopathy in Patients Confirmed by Genetic Analyses.
Zhang Huili, et al. Frontiers in neurology 2021 0 540098 - Dysferlinopathy in a cohort of Chinese patients: clinical features, mutation spectrum, and imaging findings.
Guo Qi-Fu, et al. Chinese medical journal 2021 0 (5) 622-624 - Genetic Profile of Patients with Limb-Girdle Muscle Weakness in the Chilean Population.
Cerino Mathieu, et al. Genes 2022 0 (6) - Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.
Chakravorty Samya et al. Frontiers in neurology 2020 11559327
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: